Based on RNA sequencing from the database, HBP1 and p21 were frequently down-regulated in uterine cancer, colon cancer, rectum cancer, lung cancer, liver cancer, and stomach cancer, whereas EZH2 was frequently up-regulated in these cancers (supplemental Fig. S2). This evidence concerns the gene HBP1 and gastric cancer.